INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 364 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $219,000 | -51.2% | 1,850 | -44.8% | 0.13% | -54.5% |
| Q3 2021 | $449,000 | -26.0% | 3,350 | -10.7% | 0.29% | -26.3% |
| Q2 2021 | $607,000 | +101.7% | 3,750 | 0.0% | 0.39% | +84.8% |
| Q1 2021 | $301,000 | +47.5% | 3,750 | 0.0% | 0.21% | +40.9% |
| Q4 2020 | $204,000 | +1754.5% | 3,750 | +435.7% | 0.15% | +1390.0% |
| Q1 2019 | $11,000 | +10.0% | 700 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $10,000 | -50.0% | 700 | 0.0% | 0.01% | -44.4% |
| Q3 2018 | $20,000 | +5.3% | 700 | 0.0% | 0.02% | 0.0% |
| Q2 2018 | $19,000 | +26.7% | 700 | 0.0% | 0.02% | +20.0% |
| Q1 2018 | $15,000 | +15.4% | 700 | 0.0% | 0.02% | +25.0% |
| Q4 2017 | $13,000 | – | 700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |